No abstract available
MeSH terms
- Antiviral Agents* / economics
- Antiviral Agents* / therapeutic use
- Betacoronavirus*
- COVID-19
- Coronavirus Infections / drug therapy
- Coronavirus Infections / epidemiology*
- Coronavirus Infections / prevention & control
- Coronavirus Infections / transmission
- Drug Discovery* / economics
- Financing, Government
- Humans
- Pandemics / prevention & control*
- Pneumonia, Viral / drug therapy
- Pneumonia, Viral / epidemiology*
- Pneumonia, Viral / prevention & control
- Pneumonia, Viral / transmission
- Population Surveillance
- SARS-CoV-2
- Viral Vaccines*
Substances
- Antiviral Agents
- Viral Vaccines